Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Acquisitions (Details Textual)

Note 3 - Acquisitions (Details Textual) - USD ($) $ in Thousands			8 Months Ended		9 Months Ended		12 Months Ended
	Aug. 01, 2016	Jul. 01, 2016	Mar. 31, 2017	Mar. 31, 2017	Mar. 31, 2017	Mar. 31, 2016	Jun. 30, 2016
Payments to Acquire Businesses, Net of Cash Acquired					$ 253,941	$ 90,888
Business Combination, Contingent Consideration, Liability			$ 70,480	$ 70,480	70,480		$ 38,500
Goodwill, Purchase Accounting Adjustments					1,809
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability					$ (9,117)
Developed Technology Rights [Member]
Finite-Lived Intangible Asset, Useful Life					15 years
Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life					7 years 182 days
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life					10 years
Noncompete Agreements [Member]
Finite-Lived Intangible Asset, Useful Life					2 years
Space [Member]
Payments to Acquire Businesses, Gross		$ 9,000
Payments to Acquire Businesses, Net of Cash Acquired		6,700			$ 6,747
Business Combination, Consideration Transferred, Liabilities Incurred		$ 2,300			2,256
Advanced Cell Diagnostics (ACD) [Member]
Payments to Acquire Businesses, Gross	$ 258,000
Payments to Acquire Businesses, Net of Cash Acquired	246,193		734		246,927
Business Combination, Consideration Transferred, Liabilities Incurred				11,000	10,970
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	75,000		75,000	75,000	75,000
Goodwill, Purchase Accounting Adjustments			4,677	4,700
Business Combination, Consideration Transferred, Liabilities Incurred, Adjustment			10,970	11,000
Business Combination, Working Capital, Subsequent Adjustment				700
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Noncurrent, Adjustment			(7,027)	7,000
Advanced Cell Diagnostics (ACD) [Member] \| The 2016 Revenue Equal or Exceed $30 Milliom [Member]
Business Combination, Contingent Consideration, Liability	25,000
Business Combination, Contingent Consideration, Liability, Trigger Amount of Revenue	30,000
Advanced Cell Diagnostics (ACD) [Member] \| The 2017 Revenues Equal or Exceed $45 Million [Member]
Business Combination, Contingent Consideration, Liability	50,000
Business Combination, Contingent Consideration, Liability, Trigger Amount of Revenue	45,000
Advanced Cell Diagnostics (ACD) [Member] \| The 2016 Revenue Hurdle Not Met and 2017 Revenue Hurdle Met [Member]
Business Combination, Contingent Consideration, Liability	$ 25,000
Zephyrus [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 7,000	$ 7,000	7,000
Goodwill, Purchase Accounting Adjustments							$ 1,800
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability					3,000
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles					900
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets					$ 300